Recurrent genital herpes simplex virus infection in guinea pigs
- PMID: 3000982
- DOI: 10.1159/000149647
Recurrent genital herpes simplex virus infection in guinea pigs
Abstract
After recovery from initial genital herpes simplex virus (HSV) infections, female guinea pigs developed spontaneous recurrent infections characterized by discrete erythematous or vesicular herpetic lesions on the external genital skin. HSV type 2 (HSV2) caused significantly more recurrent infections in guinea pigs than did HSV type 1 (HSV1). HSV2-infected animals demonstrated a significant decline in frequency of recurrences over time. The viral nature of the recurrent lesions was confirmed by recovery of infectious HSV, detection of HSV antigen, and histologic examination. Latent HSV2 could be demonstrated in dorsal root ganglia and external genital skin after recovery from the primary infection. Recurrent genital HSV infection in the guinea pig shares many features with recurrent genital herpes in humans and provides a model for studying the relationship between latency and recurrences and for exploring methods for control of recurrent disease.
Similar articles
-
Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease.J Infect Dis. 1982 Sep;146(3):397-404. doi: 10.1093/infdis/146.3.397. J Infect Dis. 1982. PMID: 6286797
-
Zosteriform spread of herpes simplex virus type 2 genital infection in the guinea-pig.J Gen Virol. 1986 Sep;67 ( Pt 9):1851-7. doi: 10.1099/0022-1317-67-9-1851. J Gen Virol. 1986. PMID: 3018127
-
Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent, and latent genital infections with herpes simplex virus type 2 in guinea pigs.J Infect Dis. 1988 May;157(5):897-902. doi: 10.1093/infdis/157.5.897. J Infect Dis. 1988. PMID: 2834467
-
Evaluation of herpes simplex virus vaccines in animals: the guinea pig vaginal model.Rev Infect Dis. 1991 Nov-Dec;13 Suppl 11:S920-3. doi: 10.1093/clind/13.supplement_11.s920. Rev Infect Dis. 1991. PMID: 1664129 Review.
-
Infection with herpes-simplex viruses 1 and 2. II.N Engl J Med. 1973 Oct 4;289(14):719-25. doi: 10.1056/NEJM197310042891404. N Engl J Med. 1973. PMID: 4353782 Review.
Cited by
-
Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs.BMC Microbiol. 2010 Jun 3;10:163. doi: 10.1186/1471-2180-10-163. BMC Microbiol. 2010. PMID: 20525279 Free PMC article.
-
Herpes Simplex Virus 2 in Autonomic Ganglia: Evidence for Spontaneous Reactivation.J Virol. 2019 May 15;93(11):e00227-19. doi: 10.1128/JVI.00227-19. Print 2019 Jun 1. J Virol. 2019. PMID: 30894469 Free PMC article.
-
The opportunities and challenges of epigenetic approaches to manage herpes simplex infections.Expert Rev Anti Infect Ther. 2024 Dec;22(12):1123-1142. doi: 10.1080/14787210.2024.2420329. Epub 2024 Nov 6. Expert Rev Anti Infect Ther. 2024. PMID: 39466139 Review.
-
Downstream regulatory elements increase acute and latent herpes simplex virus type 2 latency-associated transcript expression but do not influence recurrence phenotype or establishment of latency.J Virol. 1996 Mar;70(3):1535-41. doi: 10.1128/JVI.70.3.1535-1541.1996. J Virol. 1996. PMID: 8627672 Free PMC article.
-
Persistent genital herpes simplex virus-2 shedding years following the first clinical episode.J Infect Dis. 2011 Jan 15;203(2):180-7. doi: 10.1093/infdis/jiq035. Epub 2010 Dec 9. J Infect Dis. 2011. PMID: 21288817 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical